Pediatric Neurological Disorder Diagnosis through Advanced Neuroimaging and Genomic Integration Techniques

Abstract

Background: Pediatric neurological disorders such as epilepsy, autism spectrum disorder, cerebral palsy, neurodevelopmental syndromes and inherited neurological conditions pose a significant healthcare challenge because of their complex etiology and diverse clinical manifestation. The early detection of underlying neurological abnormalities is often difficult for conventional diagnostic methods. Recent advances in neuroimaging and genomic technologies have opened new avenues for improving diagnostic accuracy and personalized clinical management. Objective: To examine the effect of advanced neuroimaging and genomic integration approaches on the diagnosis and clinical evaluation of pediatric neurological disorders. Methodology: A prospective observational study was conducted in 300 children with suspected neurological disorders. We integrated advanced neuroimaging modalities, such as magnetic resonance imaging (MRI), functional MRI (fMRI), diffusion tensor imaging (DTI), and genomic sequencing technologies, into the diagnostic workflow. We used clinical, imaging and genetic data over 12 months to evaluate diagnostic effectiveness and outcome improvement. Findings: Diagnostic accuracy increased from 78.5% to 95.2% and early disease detection improved by 21.8%. We achieved 93.6% accuracy in genetic variant identification and reduced diagnostic turnaround time by 34.7%. Overall effectiveness of clinical decision-making improved to 92.4% Conclusion: The combination of advanced neuroimaging and genomic technologies provides substantial benefits in the diagnosis of pediatric neurological disorders, including enhanced diagnostic accuracy, early detection, and customized clinical decision-making. These technologies represent a promising platform for precision neurology and enhanced patient outcomes.